Solventum Corp | SOLV - Gross Profit On Sales

Stock Price
77.57
Daily Change
0.59 0.77%
Monthly
-7.92%
Yearly
5.71%
Q1 Forecast
74.60

Solventum Corp reported $1.14B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
Baxter International USD 950M 194M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Cencora USD 2.96B 48.98M Sep/2025
Dexcom USD 688.8M 99.8M Jun/2025
Insulet USD 510.1M 57.9M Sep/2025
Solventum Corp USD 1.14B 40M Sep/2025
West Pharmaceutical Services USD 294.3M 20.4M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025